Vimarsana
Biggest News Aggregation in the World

Page 2 - Biolojic Design News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biolojic Design. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biolojic Design Today - Breaking & Trending Today

Aulos Bioscience Raises $20M in Series A Extension Financing - Vimarsana News

Aulos Bioscience Raises $20M in Series A Extension Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Made in Israel: First AI-designed Antibody Could Lead to Eradication of Tumors - Tech News - Vimarsana News

Made in Israel: First AI-designed Antibody Could Lead to Eradication of Tumors - Tech News

A Computer May Design the Perfect Antibody to Fight Cancer in a Breakthrough for Medicine. Prof. Yanay Ofran Explains Why Testing It on Mice Can Be Misleading, and What Limits Creativity in Biotech Companies: 'They're Searching for a New Biology and Trying to Treat It Using Old Technology. We Do the Opposite'

Israeli company programs antibodies to fight cancer - Vimarsana News

Israeli company programs antibodies to fight cancer

Biolojic Design working on what they describe as 'breakthrough antibodies' able to target specific cancer cells that are harder to detect and operate on

Israeli Company Biolojic Design Programs Antibodies To Fight Cancer - Vimarsana News

Israeli Company Biolojic Design Programs Antibodies To Fight Cancer

Biolojic Design working on what they describe as 'breakthrough antibodies' - Click the link for more details

Source: i24news.tv
Related Topics:
Yanay OfranBiolojic Design
Cancer patients trialing world's first 'nano-robot' antibodies, made in Israel - Vimarsana News

Cancer patients trialing world's first 'nano-robot' antibodies, made in Israel

Computer-designed antibodies can be programmed to do much more when designed from scratch than when based on animal/human antibodies, says inventor